Northrook, IL -- (SBWIRE) -- 12/10/2019 -- Rising focuses on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of the market.

What the Market Looks Like?

Predicted to grow at a CAGR of 20.3% during the forecast period, the global 3D Cell Culture Market is estimated to reach USD 1,720.3 Million by the end of 2022

Focus on developing alternatives to animal testing

Animal models are widely used in cell biology research for studying human-specific diseases. However, this carries several disadvantages—the possibility of harm to animals, difficulties in ensuring result accuracy due to differences in species, disease mechanisms, and drug responses. To overcome these issues, various institutes are involved in developing alternative methods for drug development. The Directive on the Protection of Animals Used for Scientific Purposes (2010/63); the Regulation on Cosmetic Products (1223/2009); REACH (2007/2006); and Classification, Labeling, and Packaging (CLP) (1272/2008) are some European regulations that strongly encourage the replacement of animal testing. Additionally, the Canadian Centre for Alternatives to Animal Methods and Canadian Centre for the Validation of Alternative Methods; Cruelty Free International; and the Fund for the Replacement of Animals in Medical Experiments oppose the use of animal-based models for research.

Applications, is segmented into cancer and stem cell research, drug discovery and toxicology testing, and tissue engineering & regenerative medicine. The cancer and stem cell research segment is estimated to account for the largest market share in 2017. Growth of this application segment is attributed to increasing incidence of cancer and significant funding initiatives for cancer research from government as well as private organizations.

Based on end users, the market is segmented into pharmaceutical & biotechnology companies and research institutes. In 2017, pharmaceutical and biotechnology companies are expected to form the largest end-user segment. The presence of a large number of pharmaceutical and biotechnology companies, increasing R&D spending in these companies, and growing focus on alternative testing models instead of animal techniques are the key drivers for this end-user segment.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847

What Drives the Market?

The growth of the global market for 3D Cell Culture is primarily influenced by the following factors:

- Focus on Developing Alternatives to Animal Testing.
- Availability of Funding for Research.
- Technological Advancements & New Product Launches.
- Growing Awareness

Geographical growth scenario of 3D Cell Culture Market:

Geographically, the market is dominated by North America, followed by Europe, Asia Pacific, and the Rest of the World (RoW). The dominance of the North American market is attributed to factors such as increase in incidence of cancer, presence of well-established pharmaceutical and biotechnology industry, and availability of technologically advanced products.

Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=191072847

Leading market players and strategies adopted

The 3D cell culture market is highly competitive with the presence of several small and big players. Some of the players in the 3D cell culture market include Thermo Fisher (US), Corning (US), Lonza (Switzerland), Merck (Germany), ReproCELL (Japan), and InSphero (Switzerland). The other players operating in this market include Global Cell Solutions (US), Synthecon (US), 3D Biotek (US), Kuraray (Japan), Hamilton Company (US), Mimetas (Netherlands), Emulate (US), Nano3D Biosciences (US), and QGel (Switzerland).

While the Laboratory Informatics market represents significant growth opportunities, market growth may be hindered due to a lack of infrastructure for 3D cell culture research. The market is highly competitive with the presence of several big and small players.

Request Bundle Reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=191072847

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com